search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Directory of Companies


Roche Diagnostics Limited Charles Avenue Burgess Hill


West Sussex RH15 9RY Contact: Katie Fisher T: +44(0) 1444 256720 E: katie.fisher@roche.com W: www.roche.co.uk


Sarstedt Ltd 68 Boston Road Leicester LE4 1AW


Contact: Rob Heald T: 0116 235 9023 E: info.gb@sarstedt.com W: www.sarstedt.com


ScheBo Biotech UK Ltd PO Box 6359 Basingstoke RG22 4WE


Sakura Finetek


Thatcham Business Village, Colthrop Way, Thatcham RG19 4LW T: 0845 070 1638 E: d.byrne@sakura.eu W: www.sakura.com


Our mission is to advance cancer diagnostics by providing integrated solutions for anatomic pathology and patients through best-in-class innovation. We want to be the first company to fully automate and standardise anatomic pathology through smarter solutions to enable accurate and fast diagnoses to optimise treatment success for each life we touch. We empower pathology professionals, and


we are leading the transformation of today’s Pathology services to meet the challenges of today and tomorrow. When it comes to diagnosing cancer, there’s no time to wait.


Product Listing Automated Staining Reagents • Automated Staining Systems • Embedding Systems • Histopathology • Laboratory Automation • Microtomy • Rapid Tissue Processing • Stainers • Tissue Science • Tissue Embedding • Tissue Processors • Waxes


36 l THE BIOMEDICAL SCIENCE INDUSTRY HANDBOOK 2020


Contact: Ivor Smith T: 01256 477259 E: i.smith@schebo.co.uk W: www.schebo.co.uk


ScheBo® Biotech has a reputation for


laboratory tests that deliver real clinical benefits. Pancreatic exocrine insufficiency (PEI)


commonly occurs in cystic fibrosis and chronic pancreatitis, but may currently be overlooked in diabetes or coeliac disease for example. In patients presenting with gastrointestinal


symptoms, our ‘faecal elastase tests’ assist diagnosis.


M2-PK is important in tumour glucose metabolism. Screening for colorectal cancer with ‘faecal M2-PK’ delivers patient convenience, high sensitivity and specificity. The ‘blood test’ supports diagnosis, monitoring therapy response and post-therapy follow-up in numerous cancers. Our faecal lactoferrin and calprotectin tests


are reliable and economical non-invasive markers of gastrointestinal inflammation.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76